KAT2B and hepatocellular carcinoma: Additionally*** [17]***, KAT2B is also capable of acetylating histone H4, inhibiting AKT signal as well as regulating GLI1/Bcl-2/Bax axis to induce apoptosis, thereby inhibiting occurrence and hepatocellular carcinoma development [14,18].